Cargando…
Correction: Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Autores principales: | Ahmadizar, Fariba, Onland-Moret, N. Charlotte, de Boer, Anthonius, Liu, Geoffrey, Maitland-van der Zee, Anke H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619590/ https://www.ncbi.nlm.nih.gov/pubmed/26492353 http://dx.doi.org/10.1371/journal.pone.0141704 |
Ejemplares similares
-
Efficacy and Safety Assessment of the Addition of Bevacizumab to Adjuvant Therapy Agents in Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ahmadizar, Fariba, et al.
Publicado: (2015) -
Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
por: van den Heuvel, Jan Maurik, et al.
Publicado: (2020) -
Systematic Review of Pharmacogenetic Warfarin Dosing
por: van Schie, Rianne M. F., et al.
Publicado: (2009) -
Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings
por: Verhoef, Talitha I., et al.
Publicado: (2014) -
Correction to: SB8: A Bevacizumab Biosimilar
por: Syed, Yahiya Y.
Publicado: (2020)